A panel for the US Food and Drug Administration voted unanimously with one abstention today to endorse lower doses of Pfizer's coronavirus vaccine for 5- to 11-year-olds. The FDA is expected to make its own decision within days, and then the Centers for Disease Control and Prevention would decide on its own recommendation.